Critics concerned GLP-1 drugs may give athletes a performance edge

Experts are raising alarms over GLP-1 drugs, commonly used for weight loss, which may also offer athletes an unexpected performance boost, sparking calls for their ban in professional sports. This debate centers on whether these medications, known for their metabolic benefits, could provide an unfair competitive advantage, challenging the integrity of athletic competitions. The implications extend beyond just the sports arena, as it raises questions about the ethical use of pharmaceuticals in enhancing human performance.